Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Hypotonic Cisplatin Treatment After Marginal Resection of Fibrosarcoma: A Preliminary Report.

Anticancer research·2026
Same author

Effect of biliary drainage and biliary tract infection in unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: a multicenter, prospective cohort study (NAPOLEON-2).

BMC cancer·2026
Same author

Hispidin Ameliorates Acute Ultraviolet B-Induced Skin Inflammation by Targeting Reactive Oxygen Species-Dependent Neutrophil Extracellular Trap Formation.

International journal of molecular sciences·2026
Same author

Predictors of prolonged progression-free survival in patients with unresectable or recurrent pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid (NAPOLEON-2 study).

Therapeutic advances in medical oncology·2026
Same author

Orally Administered Rhamnan Sulfate from <i>Monostroma nitidum</i> Significantly Inhibits Melanoma Metastasis in Lungs and Aorta of Mice Implanted with B16 Cells.

Marine drugs·2026
Same author

Strain-Dependent and Site-Specific Differences in Irinotecan-Induced Skin Pigmentation in Mice.

Biological & pharmaceutical bulletin·2026

Related Experiment Video

Updated: Jun 6, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Plasma cluster ions decrease the antigenicity of mite allergens and suppress atopic dermatitis in NC/Nga mice.

Keiichi Hiramoto1, Kumi Orita, Yurika Yamate

  • 1Department of Biochemistry and Molecular Pathology, Osaka City University Medical School, Asahimachi, Abeno, Japan. hiramoto@msic.med.osaka-cu.ac.jp

Archives of Dermatological Research
|November 18, 2010
PubMed
Summary
This summary is machine-generated.

A novel air cleaner using plasma cluster ions significantly reduced atopic dermatitis (AD) symptoms in mice. The technology effectively destroyed mite allergens, offering a potential new approach for managing AD.

More Related Videos

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Area of Science:

  • Immunology
  • Environmental Science
  • Dermatology

Background:

  • Mite allergens are significant contributors to atopic dermatitis (AD) pathogenesis.
  • Existing treatments for AD can be limited, necessitating novel approaches.
  • Environmental allergen control is crucial for managing allergic diseases.

Purpose of the Study:

  • To evaluate the efficacy of a novel air cleaner (KC-850U) utilizing charged plasma cluster ions in mitigating AD symptoms induced by mite allergens.
  • To investigate the mechanism by which plasma cluster ions affect mite allergens.

Main Methods:

  • ELISA was used to quantify immunoglobulin E (IgE) binding to mite allergens pretreated with plasma cluster ions.
  • Kinetic analysis assessed the impact of plasma cluster ions on allergen epitopes.
  • Mice models of AD were housed in environments with either the novel air cleaner or a standard one to observe dermal symptom development over two weeks.

Main Results:

  • Exposure to plasma cluster ions destroyed approximately 95% of mite allergen epitopes.
  • Conventional mice exposed to the novel air cleaner showed remarkable suppression of AD symptoms compared to controls.
  • Mice housed with a standard air cleaner still exhibited AD symptoms.

Conclusions:

  • Plasma cluster ions generated by the KC-850U air cleaner effectively destroy mite allergen epitopes.
  • The KC-850U air cleaner demonstrates significant potential in suppressing mite-induced atopic dermatitis symptoms.
  • This technology offers a promising non-invasive strategy for environmental management of AD.